Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vigouroux

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Bone Marrow Transplantation|January 24, 2017
Carmustine replacement in intensive chemotherapy preceding reinjection of autologous HSCs in Hodgkin and non-Hodgkin lymphoma: a reviewG Damaj, J Cornillon, K Bouabdallah, et al.
Cytotherapy|July 10, 2003
Expansion of EBV latent membrane protein 2a specific cytotoxic T cells for the adoptive immunotherapy of EBV latency type 2 malignancies: influence of recombinant IL12 and IL15H-J Wagner, U Sili, B Gahn, et al.
Bone Marrow Transplantation|June 4, 2013
Allogeneic SCT for patients with high-risk peripheral T-cell lymphoma in first responseM Robles, S Vigouroux, R Tabrizi, et al.
Bone Marrow Transplantation|June 6, 2017
Severe acute GvHD following administration of ipilimumab for early relapse of AML after haploidentical stem cell transplantationF-X Gros, T Cazaubiel, E Forcade, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2014
90Y-ibritumomab tiuxetan, fludarabine, busulfan and antithymocyte globulin reduced-intensity allogeneic transplant conditioning for patients with advanced and high-risk B-cell lymphomasK Bouabdallah, S Furst, J Asselineau, et al.
Bone Marrow Transplantation|March 12, 2014
Allo-SCT for  Philadelphia-negative myeloproliferative neoplasms in blast phase: a study from the Societe Française de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)X Cahu, P Chevallier, A Clavert, et al.
Bone Marrow Transplantation|February 21, 2017
Scleral lenses for severe chronic GvHD-related keratoconjunctivitis sicca: a retrospective study by the SFGM-TCL Magro, J Gauthier, M Richet, et al.
Leukemia|June 16, 2012
Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantationF Baron, M Labopin, D Niederwieser, et al.
Bone Marrow Transplantation|January 15, 2014
Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationF Baron, M Labopin, D Blaise, et al.
Journal of Internal Medicine|October 5, 2017
Occurrence of graft-versus-host disease increases mortality after umbilical cord blood transplantation for acute myeloid leukaemia: a report from Eurocord and the ALWP of the EBMTF Baron, A Ruggeri, E Beohou, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Bone Marrow Transplantation|January 24, 2017
Carmustine replacement in intensive chemotherapy preceding reinjection of autologous HSCs in Hodgkin and non-Hodgkin lymphoma: a reviewG Damaj, J Cornillon, K Bouabdallah, et al.
Cytotherapy|July 10, 2003
Expansion of EBV latent membrane protein 2a specific cytotoxic T cells for the adoptive immunotherapy of EBV latency type 2 malignancies: influence of recombinant IL12 and IL15H-J Wagner, U Sili, B Gahn, et al.
Bone Marrow Transplantation|June 4, 2013
Allogeneic SCT for patients with high-risk peripheral T-cell lymphoma in first responseM Robles, S Vigouroux, R Tabrizi, et al.
Bone Marrow Transplantation|June 6, 2017
Severe acute GvHD following administration of ipilimumab for early relapse of AML after haploidentical stem cell transplantationF-X Gros, T Cazaubiel, E Forcade, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2014
90Y-ibritumomab tiuxetan, fludarabine, busulfan and antithymocyte globulin reduced-intensity allogeneic transplant conditioning for patients with advanced and high-risk B-cell lymphomasK Bouabdallah, S Furst, J Asselineau, et al.
Bone Marrow Transplantation|March 12, 2014
Allo-SCT for  Philadelphia-negative myeloproliferative neoplasms in blast phase: a study from the Societe Française de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)X Cahu, P Chevallier, A Clavert, et al.
Bone Marrow Transplantation|February 21, 2017
Scleral lenses for severe chronic GvHD-related keratoconjunctivitis sicca: a retrospective study by the SFGM-TCL Magro, J Gauthier, M Richet, et al.
Leukemia|June 16, 2012
Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantationF Baron, M Labopin, D Niederwieser, et al.
Bone Marrow Transplantation|January 15, 2014
Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationF Baron, M Labopin, D Blaise, et al.
Journal of Internal Medicine|October 5, 2017
Occurrence of graft-versus-host disease increases mortality after umbilical cord blood transplantation for acute myeloid leukaemia: a report from Eurocord and the ALWP of the EBMTF Baron, A Ruggeri, E Beohou, et al.
Pageof 3